XML 65 R42.htm IDEA: XBRL DOCUMENT v3.21.1
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Net Revenue [1] $ 25,027,637 $ 6,347,160
United States    
Net Revenue 18,367,000 5,002,000
International    
Net Revenue 6,661,000 1,345,000
SteraMist Product    
Net Revenue 22,971,000 4,999,000
Service & Training    
Net Revenue $ 2,057,000 $ 1,348,000
[1] Share amounts with respect to the common stock and Convertible Series A Preferred Stock have been retroactively restated to reflect the reverse split thereof, which was effected as of the close of business on September 10, 2020. Refer to Note 11 - Equity for further information.